Position in ARCT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,297,046
-$240,851 QoQ
Shares Held
490,632
+7.1% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Derivatives in ARCT
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$366,757
PutShares
19,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ARCT ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ARCT
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,297,046 | 490,632 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,537,897 | 458,277 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,396,982 | 227,893 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,957,755 | 160,486 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $366,757 | 19,900 | Put | Defined | 2025-11-13 | |
| 2025-06-30 | $721,325 | 55,444 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $630,569 | 59,544 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $900,613 | 53,071 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,226,832 | 52,858 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,513,570 | 62,159 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,645,098 | 107,939 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,292,482 | 72,708 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $798,742 | 31,262 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $487,615 | 17,002 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $987,706 | 41,206 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,443,667 | 85,122 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $51,573 | 3,480 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $579,955 | 36,846 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,452,254 | 202,235 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,665,100 | 99,030 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,288,014 | 89,745 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,149,578 | 33,971 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,768,052 | 42,810 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,220,192 | 28,128 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $597,510 | 13,928 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $742,603 | 15,888 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $3,383 | 249 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||